PATENT CLAIM ANALYSIS

Application Number: 16055588
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-06
Patent Classification: ["514", "171000"]

Abstract:
The present disclosure is directed to generally methods and/or compositions for treating mammographic breast density and/or breast stiffness in a patient in need thereof, such as a pre-menopausal, a peri-menopausal or a post-menopausal patient, comprising the administration of an effective amount of androgenic agent and an effective amount of an aromatase inhibitor. The present disclosure is also directed to methods and/or compositions for reducing breast pain. The present disclosure is also directed to method and/or compositions for reducing elasticity and/or decreasing mechano-transduction on the genome of breast cells. The present disclosure is also directed to methods and/or compositions for stabilizing and/or increasing the levels of androgen receptor expression in breast tissue.

Claim (Index 11):
The method of any one of  claims 1 - 10 , wherein the method provides one or more of the following: i) enhances mammographic detection due to reduced breast density enabling the mammogram to visualize malignancy at an earlier and/or less aggressive stage;\n ii) enhances the ability to achieve better mammographic compression due at least in part due to reduced pain; \n iii) enhances the ability to achieve better patient compliance in having regular mammographic check-ups; \n iv) enhances the ability to treat the patient and at the same time not causing perturbations in the hypothalamic-pituitary axis and/or other endocrine axis; \n v) reduces breast pain in a patient; \n vi) reduces breast elasticity in a patient; \n vii) decrease mechano-transduction on the genome of a cell in order to reduce the risk of malignant transformation in a patient; \n viii) increases ratio of fibro-glandular and adipose tissue in a patient; \n ix) increases CD36 in a patient; \n x) stabilizes and/or an increase in levels of androgen receptor expression in breast tissue of a patient; \n xi) increases the level of GCDFP15 in a patient; \n xii) reduces BPE in an MRI image of a patient; and \n xiii) reduces cysts in size and/or quantity in a patient's breast.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 96.0
- Lexical Diversity: 2.03448
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15490309', '15520278', '15460895', '14920192', '14853130']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7971047019775231
- 35 USC 102 Novelty (BERT): 0.6918686740907093
- Combined Prediction Score: 0.7865810991888418
- Mean Citation Score: 537.251696
- Max Citation Score: 725.0079
- Similarity Product: 680.4768174409031

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test